Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Accenture
Cerilliant
Fuji
Chubb
QuintilesIMS
Deloitte
Argus Health

Generated: August 21, 2018

DrugPatentWatch Database Preview

Monarch Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for MONARCH PHARMS, and what generic and branded alternatives to MONARCH PHARMS drugs are available?

MONARCH PHARMS has twenty-two approved drugs.



Summary for Monarch Pharms
US Patents:0
Tradenames:17
Ingredients:14
NDAs:22

Drugs and US Patents for Monarch Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Monarch Pharms PEDIOTIC hydrocortisone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OTIC 062822-001 Sep 29, 1987 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Monarch Pharms MENEST estrogens, esterified TABLET;ORAL 084950-001 Approved Prior to Jan 1, 1982 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Monarch Pharms POLYSPORIN bacitracin zinc; polymyxin b sulfate OINTMENT;OPHTHALMIC 061229-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Monarch Pharms PROLOPRIM trimethoprim TABLET;ORAL 017943-003 Jul 14, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Monarch Pharms CORTISPORIN bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate OINTMENT;TOPICAL 050168-002 May 4, 1984 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Monarch Pharms KEMADRIN procyclidine hydrochloride TABLET;ORAL 009818-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Monarch Pharms MENEST estrogens, esterified TABLET;ORAL 084948-001 Approved Prior to Jan 1, 1982 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Monarch Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Monarch Pharms QUIBRON-T/SR theophylline TABLET, EXTENDED RELEASE;ORAL 087563-001 Jun 21, 1983 4,465,660 ➤ Try a Free Trial
Monarch Pharms SEPTRA DS sulfamethoxazole; trimethoprim TABLET;ORAL 017376-002 Approved Prior to Jan 1, 1982 4,209,513 ➤ Try a Free Trial
Monarch Pharms SEPTRA sulfamethoxazole; trimethoprim TABLET;ORAL 017376-001 Approved Prior to Jan 1, 1982 4,209,513 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Fuji
Merck
Express Scripts
Medtronic
Johnson and Johnson
Julphar
Covington
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.